Braze, Inc. Class A Common Stock
BRZE
$45.86
+0.39%
Braze, Inc. is a customer engagement platform that enables brands to orchestrate personalized, cross-channel interactions with consumers, spanning data ingestion, classification, orchestration, personalization, and action, all powered by its Sage AI engine. The company serves retail and e-commerce, media and entertainment, financial services, and travel and hospitality verticals, with the majority of revenue generated in the United States. Braze occupies a distinct position as a pure-play, vertically integrated engagement platform competing against larger marketing clouds and point solutions, and its subscription-heavy model (subscription revenue of $193.5 million versus $11.7 million in professional services in the latest quarter) underscores its SaaS identity. The current investor narrative centers on whether AI is a tailwind or a threat: recent headlines highlight strong AI-driven revenue growth and a Q1 fiscal 2027 earnings beat with raised guidance, but also recurring fears that AI infrastructure spending could crowd out software budgets, alongside persistent profitability concerns that keep the stock in a speculative bucket for some investors.…
BRZE
Braze, Inc. Class A Common Stock
$45.86
Related headlines
Investment Opinion: Should I buy BRZE Today?
The synthesized recommendation is a Hold with a speculative bias. The core thesis is that Braze offers a high-growth, AI-driven customer engagement platform at a deeply compressed valuation, but persistent GAAP losses and recent negative momentum warrant caution. The analyst consensus is strong buy with an average target of $37.30, implying 55.8% upside, but these targets are stale and may not reflect the September crash.
Supporting evidence includes revenue growth of 27.91% YoY, a PS ratio of 3.04x (down from 11.01x in January 2026), positive trailing free cash flow of $60.80 million, and a low debt-to-equity of 0.13. However, net margin is -15.40% and operating margin is -8.16%, and gross margin has compressed to 65.48% from 69.26%. The forward PE of 24.38x implies the market expects a profitability inflection, which is not yet assured.
The biggest risks are continued GAAP losses, decelerating revenue growth, and competitive pressures. The rating would upgrade to Buy if the company demonstrates sustained revenue growth above 25% with improving margins and positive GAAP earnings, or if the stock price stabilizes above $30. It would downgrade to Sell if revenue growth falls below 20% or if free cash flow turns negative. Relative to its history, the stock is undervalued, but relative to profitable peers, it is fairly valued given its lack of earnings.
Sign up to view all
BRZE 12-Month Price Forecast
Braze presents a balanced risk/reward profile. The company's robust revenue growth and AI-driven demand are offset by persistent unprofitability and recent negative momentum. The valuation is attractive relative to its own history, but the lack of GAAP profits and competitive pressures warrant a neutral stance. A clear path to profitability and sustained revenue growth above 25% would make me bullish, while a slowdown below 20% or further margin compression would make me bearish. The stock is suitable for risk-tolerant investors with a long-term horizon.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Braze, Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $47.54 and implied upside of +3.7% versus the current price.
Average Target
$47.54
0 analysts
Implied Upside
+3.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$48 - $48
Analyst target range
Coverage is robust, with 20 analysts covering the stock and a consensus recommendation of "strong_buy" (recommendation mean of 1.29, where 1.0 is a strong buy). The average target price is $37.30, which implies approximately +55.8% upside from the current price of $23.94, a strikingly large gap that suggests either significant undervaluation or stale targets that have not yet been revised following the September 9 collapse. The consensus leans decisively bullish, and the institutional ratings list shows a uniform wall of Buy/Overweight/Outperform ratings from JP Morgan, Oppenheimer, Piper Sandler, BTIG, Mizuho, Citigroup, DA Davidson, Barclays, Needham, and Cantor Fitzgerald, all dated March 25, 2026, with no downgrades or negative actions visible. The absence of recent rating changes is notable: the ratings are all from March, before the summer rally and the September crash, so they may not reflect the latest information. The target range spans $30.00 to $50.00, a wide $20 spread that signals high uncertainty and low conviction on the exact magnitude of the opportunity. The high target of $50.00 assumes multiple expansion and accelerating AI-driven growth, potentially with a path to sustained profitability and re-rating toward premium SaaS multiples; the low target of $30.00, still 25.3% above the current price, prices in continued execution but with margin compression or slower growth. The fact that even the low target is above the current price suggests analysts collectively view the selloff as overdone, but the wide spread and the lack of post-September revisions mean the consensus may be lagging the market's new information. Investors should treat the strong_buy consensus with caution until targets are refreshed, as the 55.8% implied upside is only credible if the September catalyst was a temporary shock rather than a fundamental deterioration.
Bulls vs Bears: BRZE Investment Factors
The bear case currently has stronger near-term evidence due to the recent 21.7% single-day collapse, negative momentum, and persistent GAAP losses, but the bull case is supported by robust 27.9% revenue growth, a strong buy consensus, and deeply compressed valuation. The most important tension is whether the September crash was a temporary shock or a fundamental deterioration in growth and profitability prospects. If the company can sustain high-20s revenue growth and show a clear path to profitability, the stock could re-rate significantly; otherwise, further downside is likely. The balance sheet is a relative strength with low debt-to-equity of 0.13 and positive trailing free cash flow, but the lack of GAAP profitability remains a key hurdle.
Bullish
- Revenue growth remains robust at 27.9% YoY: Q4 FY2026 revenue reached $205.17 million, up 27.91% year over year, with sequential growth from $162.06 million in Q1 to $205.17 million in Q4. This consistent top-line expansion demonstrates durable demand for Braze's customer engagement platform despite macro uncertainty.
- Analyst consensus strong buy with 55.8% upside: 20 analysts rate the stock a strong buy (mean 1.29) with an average target price of $37.30, implying 55.8% upside from the current $23.94. Even the lowest target of $30.00 sits 25.3% above the current price, suggesting the selloff is viewed as overdone.
- Valuation compressed to historic lows: The PS ratio has fallen to 3.04x from 11.01x at the end of the January 2026 quarter and 29.50x in January 2025, a 72% compression. This places the stock at the low end of its post-IPO valuation range, potentially pricing in excessive pessimism.
- Improving profitability and positive free cash flow: Net loss narrowed to $31.60 million in Q4 from $35.99 million in Q3, while EBITDA improved from -$31.06 million to -$14.56 million. Trailing free cash flow is positive at $60.80 million, and cash rose to $128.34 million from $101.81 million sequentially.
Bearish
- Persistent GAAP losses and negative margins: The latest quarter posted a net loss of $31.60 million with a net margin of -15.40% and operating margin of -8.16%. Despite gross margin of 65.48%, heavy sales and marketing ($81.69 million) and R&D ($45.03 million) expenses keep the company unprofitable.
- Gross margin compression: Gross margin has declined from 68.62% in Q1 FY2026 and 69.26% a year earlier to 65.48% in Q4. This 314 basis point year-over-year contraction suggests rising cost of revenue or unfavorable mix, which could pressure future profitability.
- Severe stock price collapse and negative momentum: The stock plunged 21.7% in a single session on September 9, 2026, from $30.31 to $23.725, erasing weeks of gains. The 1-month change is -13.51% and relative strength versus SPY is -12.45%, indicating a trend break and negative momentum.
- Free cash flow flattered by stock-based compensation: Q4 free cash flow of $13.50 million is exceeded by stock-based compensation of $37.71 million, meaning true economic cash generation is negative. This reliance on SBC dilutes shareholders and masks underlying cash burn.
BRZE Technical Analysis
Braze is in a recovery phase within a broader downtrend, with the current price of $23.94 sitting at roughly 38.8% of its 52-week range (52-week low of $15.26, 52-week high of $37.327). The 1-year price change of -22.47% confirms the longer-term trend remains negative, and the stock is still 35.9% below its 52-week high, meaning the recent bounce has not yet repaired the damage from the prior decline. Positioning near the lower-middle of the range suggests the market is still pricing in meaningful uncertainty rather than momentum-driven overextension. Short-term momentum has deteriorated sharply: the 1-month change of -13.51% contrasts with a positive 3-month change of +10.53% and a 6-month change of +27.54%, indicating a violent reversal in September after a strong summer rally. The most striking data point is the single-session collapse from $30.31 on September 8 to $23.725 on September 9, a roughly 21.7% drop that erased weeks of gains and signals a major negative catalyst or guidance reset. This divergence between the positive 3-month trend and the negative 1-month trend, combined with a relative strength versus SPY of -12.45% over one month, points to a trend break rather than a routine pullback, and the stock now needs to stabilize before any constructive setup can form. Key technical support sits at the 52-week low of $15.26, with intermediate support likely around the $21-$22 area where the stock consolidated in June and July; resistance is defined by the 52-week high of $37.327, with nearer resistance at the $30-$31 zone that capped the August rally. A breakdown below $21 would open the door to a retest of the $15.26 low, while a reclaim of $30 would be the first sign of a durable bottom. With a beta of 0.88, the stock is slightly less volatile than the broader market on a statistical basis, but the recent 21.7% single-day move and a max drawdown of -56.37% show that idiosyncratic event risk, not market beta, is the dominant risk factor here, which argues for smaller position sizing and wider stops.
Beta
0.91
0.91x market volatility
Max Drawdown
-56.4%
Largest decline past year
52-Week Range
$15-$46
Price range past year
Annual Return
+62.2%
Cumulative gain past year
| Period | BRZE Return | S&P 500 |
|---|---|---|
| 1m | +79.7% | -1.2% |
| 3m | +110.8% | +3.4% |
| 6m | +97.1% | +7.0% |
| 1y | +62.2% | +14.4% |
| ytd | +40.9% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BRZE Fundamental Analysis
Revenue growth remains robust but is decelerating from elevated levels: the latest quarter (ending 2026-01-31) posted revenue of $205.17 million, up 27.91% year over year, following $190.84 million in Q3, $180.11 million in Q2, and $162.06 million in Q1. The sequential progression from $162 million to $205 million over four quarters shows consistent top-line expansion, and the subscription segment at $193.5 million dwarfs professional services at $11.7 million, confirming a high-quality, recurring revenue base. However, the YoY growth rate of 27.91% compares to a prior-year Q4 growth rate that was higher on a smaller base, so the trajectory is one of gradual deceleration typical of a scaling SaaS company. The investment case hinges on whether AI-driven demand can sustain growth in the high-20s or whether competition and budget pressure push it toward the low-20s, which would compress the premium multiple. Profitability remains the central weakness: the latest quarter produced a net loss of $31.60 million and negative EPS of -$0.29, with a net margin of -15.40% and an operating margin of -8.16%. Gross margin is a healthy 65.48%, but it has compressed from 68.62% in Q1 and 69.26% a year earlier, suggesting rising cost of revenue or mix pressure. The loss narrowed from -$35.99 million in Q3 to -$31.60 million in Q4, and EBITDA improved from -$31.06 million to -$14.56 million, indicating operating leverage is beginning to materialize, but the company is still far from GAAP profitability and the gap between gross margin and net margin is consumed largely by sales and marketing ($81.69 million) and R&D ($45.03 million). The balance sheet is a relative strength: debt-to-equity is just 0.1325, the current ratio is 1.35, and trailing free cash flow is positive at $60.80 million, with Q4 free cash flow of $13.50 million and operating cash flow of $19.38 million. Cash at the end of the latest period was $128.34 million, up from $101.81 million sequentially, and the company has no meaningful debt repayment obligations. However, free cash flow is heavily flattered by stock-based compensation of $37.71 million in Q4, which exceeds the free cash flow figure, meaning true economic cash generation is thinner than reported. ROE of -21.05% and ROA of -5.77% reflect the cumulative losses, and the company remains dependent on equity issuance and SBC to fund operations, though the low leverage means solvency risk is minimal.
Quarterly Revenue
$227230000.0B
2026-07
Revenue YoY Growth
+26.2%
YoY Comparison
Gross Margin
66.8%
Latest Quarter
Free Cash Flow
$83585000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BRZE Overvalued?
Because Braze has negative trailing net income (EPS of -$0.058 and trailing PE of -17.07), the PE ratio is not meaningful, and the appropriate primary metric is the price-to-sales ratio, which stands at 3.04x on a trailing basis and 2.93x on an EV/Sales basis. The forward PE of 24.38x is the most informative valuation signal: it implies the market expects the company to swing to profitability on a forward basis, and the gap between the negative trailing PE and the positive forward PE reflects a consensus view that losses will narrow materially or turn positive in the coming year. The PEG ratio of -0.87 is negative and therefore not useful given the loss-making base, but the forward PE of 24.38x for a company growing revenue at roughly 28% is not demanding in absolute terms if the profitability inflection is real. On a peer comparison basis, the PS ratio of 3.04x is well below the historical software-sector average for high-growth SaaS names, which often trade at 5x-10x sales, and the EV/Sales of 2.93x suggests the market is applying a meaningful discount. This discount appears justified by the negative net margin of -17.79% and operating margin of -19.61%, which are inferior to profitable software peers, but it may be excessive if the forward profitability trajectory holds. The PB ratio of 3.60x is moderate and reflects a relatively asset-light balance sheet with low leverage. Historically, Braze's PS ratio has compressed dramatically: it was 11.01x at the end of the January 2026 quarter, 16.07x in October 2025, 20.09x in April 2025, and 29.50x in January 2025, meaning the current 3.04x is near the bottom of its own historical band and represents a roughly 72% compression from the January 2026 level. This compression reflects both the stock price decline and revenue growth, and it places the valuation at the low end of its post-IPO range. The interpretation is binary: either the market is correctly pricing in structural growth deceleration and persistent unprofitability, or it is offering a value opportunity in a company whose AI-driven engagement platform is gaining traction, as suggested by the Q1 fiscal 2027 earnings beat and raised guidance.
PE
-17.1x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-17.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company remains unprofitable with a net loss of $31.60 million in the latest quarter and a net margin of -15.40%, despite gross margin of 65.48%. Gross margin has compressed from 69.26% a year earlier to 65.48%, indicating rising cost of revenue or mix pressure. Free cash flow of $13.50 million in Q4 is heavily flattered by stock-based compensation of $37.71 million, meaning true economic cash generation is negative. Additionally, revenue growth, while robust at 27.91% YoY, is decelerating from higher levels, and any further slowdown could compress the premium multiple.
Market and competitive risks are pronounced. The stock trades at a PS ratio of 3.04x, which, while low relative to its own history, may still be rich given negative net margins of -17.79% and operating margins of -19.61%. The beta of 0.88 suggests lower market correlation, but the recent 21.7% single-day drop and max drawdown of -56.37% show that idiosyncratic event risk dominates. Competitive threats from larger marketing clouds and point solutions could pressure pricing and growth. Regulatory headwinds related to data privacy and AI could also impact operations.
In a worst-case scenario, a continued deceleration in revenue growth, failure to achieve profitability, and increased competition could drive the stock down to its 52-week low of $15.26, representing a 36.3% decline from the current price of $23.94. The analyst low target of $30.00 is above the current price, but if targets are revised downward post-September crash, the downside could be more severe. A breakdown below the $21 support level would likely trigger a retest of the $15.26 low. Investors could lose approximately 36% from current levels in this adverse scenario.
FAQ
The most severe risk is financial: persistent GAAP losses with a net margin of -15.40% and free cash flow flattered by stock-based compensation of $37.71 million. Competitive risk is high, as larger marketing clouds and point solutions could pressure pricing and growth. Macro risk includes potential cuts in software budgets, as highlighted by recent news about AI infrastructure spending crowding out software. Company-specific risk includes the recent 21.7% single-day stock drop, indicating high idiosyncratic volatility. Ranked by severity: financial, competitive, macro, and company-specific.
The 12-month forecast includes a bull case with 25% probability targeting $37.30-$50.00, a base case with 50% probability targeting $28.00-$37.30, and a bear case with 25% probability targeting $15.26-$30.00. The base case is most likely, assuming revenue growth stabilizes in the low-20s and profitability improves gradually. Key assumptions include no major competitive disruptions and continued AI-driven demand. The wide target range reflects high uncertainty, and the stock could surprise to the upside if profitability accelerates.
BRZE appears undervalued relative to its own history, with a PS ratio of 3.04x compared to 11.01x at the end of January 2026 and 29.50x in January 2025. However, relative to profitable software peers, the valuation is fair given its negative net margin of -15.40% and operating margin of -8.16%. The forward PE of 24.38x implies the market expects a profitability inflection, which is not yet assured. The EV/Sales of 2.93x suggests a discount to the broader SaaS sector. Overall, the market is pricing in significant uncertainty, and the stock could be undervalued if growth sustains and profitability improves.
From a risk/reward perspective, BRZE offers a compelling upside potential of 55.8% to the analyst average target of $37.30, but this is offset by significant downside risk to the 52-week low of $15.26, representing a 36% decline. The stock trades at a PS ratio of 3.04x, which is low relative to its history but reflects negative net margins of -15.40%. The recent 21.7% single-day drop and negative momentum suggest caution. It could be a good buy for risk-tolerant investors with a long-term horizon who believe in the AI-driven growth story and can withstand volatility. However, those seeking stability or near-term gains should look elsewhere.
BRZE is more suitable for long-term investment given its growth stage, lack of dividend, and high volatility (beta 0.88 but max drawdown -56.37%). The company is still scaling and investing heavily in sales and marketing, with earnings visibility low due to negative GAAP profits. Short-term trading is risky due to event-driven volatility, as seen in the 21.7% single-day drop. A suggested minimum holding period is 2-3 years to allow for potential profitability inflection and multiple expansion. Investors should size positions conservatively and use wider stops.